| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/21/2009 | EP1339690B1 N-type calcium channel antagonists for the treatment of pain |
| 01/21/2009 | EP1307588B1 Method for diagnosing or determining a risk for psychosis comprising determining an heterozygous mutation of methylenetetrahydrofolate reductase (MTHFR) |
| 01/21/2009 | EP0951466B1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 01/21/2009 | CN101351544A Transplantation of glial restricted precursor-derived astrocytes for promotion of axon growth |
| 01/21/2009 | CN101351476A Antibodies with glycosylated in the variable region |
| 01/21/2009 | CN101351466A Heterocyclic Janus kinase 3 inhibitors |
| 01/21/2009 | CN101351464A 8-[bis-(2-chloro-phenyl)-methyl]-3-phenyl-8-aza-bicyclo [3.2.1] octane-3-carboxylic acid amide as ligand for the nociceptin receptor ORL-1 |
| 01/21/2009 | CN101351455A Macrocyclic compounds useful as BACE inhibitors |
| 01/21/2009 | CN101351451A Multicyclic amino acid derivatives and methods of their use |
| 01/21/2009 | CN101351230A Implantable biocompatible immunoisolatory vehicle for delivery of GDNF |
| 01/21/2009 | CN101351214A Treatment of neurodegenerative disorders |
| 01/21/2009 | CN101351210A New use of 11-piperazin-1-yldibenzo [b,f] [1,4] thiazepine or its pharmaceutically acceptable salt and to oral pharmaceutical compositions |
| 01/21/2009 | CN101351205A 3, 11b-cis-dihydrotetrabanezine for the treatment of schizophrenia and other psychoses |
| 01/21/2009 | CN101348824A Neurocyte protective agent |
| 01/21/2009 | CN101348513A Ganoderic acid extraction method and preparation of soft capsule of ganoderic acid |
| 01/21/2009 | CN101348461A N-(3-pyridine formyloxy)-3,5-dimethyl-1-amantadine for curing senile dementia or pharmaceutical salt thereof |
| 01/21/2009 | CN101348456A Benzyl piperidine coumpound, and preparation and use thereof |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN101347600A Chinese medicine for treating swelling pain of head |
| 01/21/2009 | CN101347585A Powder medicine for gynaecologic abnormal menstruation and leukorrhea, and palsy |
| 01/21/2009 | CN101347581A Chinese medicine preparation for treating anypnia induced by nervous prostration |
| 01/21/2009 | CN101347579A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/21/2009 | CN101347578A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/21/2009 | CN101347577A Medicated wine for treating rheumatalgia |
| 01/21/2009 | CN101347576A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/21/2009 | CN101347575A Formulation for sedation and tranquilization |
| 01/21/2009 | CN101347574A Chinese medicine for treating perineural fibroma disease |
| 01/21/2009 | CN101347562A Anti-depression medicament as well as preparation method and application thereof |
| 01/21/2009 | CN101347557A Medicament composition for refreshment and intelligence development and preparation and use thereof |
| 01/21/2009 | CN101347548A Oral preparation for treating headache and preparation method |
| 01/21/2009 | CN101347545A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/21/2009 | CN101347524A Chinese medicinal composition for treating depression and preparation thereof |
| 01/21/2009 | CN101347517A Medicine for giving up drug |
| 01/21/2009 | CN101347514A Health medical pillow |
| 01/21/2009 | CN101347486A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/21/2009 | CN101347485A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/21/2009 | CN101347466A Capsules containing Ganoderma lucidum and ostrich bones as well as organs |
| 01/21/2009 | CN101347465A Xylaria nigripes fermentation liquor powder and preparation and use |
| 01/21/2009 | CN101347431A Use of flibanserin in the treatment of sexual disorders |
| 01/21/2009 | CN101347429A Stable tartaric acid ifenprodil injection and method of preparing the same |
| 01/21/2009 | CN101347422A Uses of salvianolic acid A in preventing and/or treating diabetes and complication |
| 01/21/2009 | CN101347413A Quetiapine sustained release tablets and method of preparing the same |
| 01/21/2009 | CN101347239A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/21/2009 | CN101347238A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/21/2009 | CN101347236A Sober-up vinegar tea and method of preparing the same |
| 01/21/2009 | CN100453549C 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 01/21/2009 | CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 01/21/2009 | CN100453078C Method for treating primary insomnia |
| 01/21/2009 | CN100453067C Preparation of injectable suspensions having improved injectabity |
| 01/20/2009 | US7479579 Genetically engineered rodent comprisingamyloid precursor protein mutation for use as tool in screening therapeutic agents for treatment of neurodegenerative diseases |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479563 Method of producing polymorphic crystals of donepezil hydrochloride |
| 01/20/2009 | US7479539 Hedgehog fusion proteins |
| 01/20/2009 | US7479506 administering a formulation comprising 2-oxo-1-pyrrolidineacetamide (piracetam) as an active ingredient and a pharmaceutically acceptable carrier for treating aphasia stage when no expectation of improvement in symptoms after at least 3 years of language rehabilitation |
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | US7479492 Use combined 5-HT1A agonists and selective serotonin reuptake inhibitors |
| 01/20/2009 | US7479488 Selected CGRP—antagonists, process for preparing them and their use as pharmaceutical compositions |
| 01/20/2009 | US7479486 Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids |
| 01/20/2009 | CA2521030C 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 01/20/2009 | CA2499698C Proline derivatives having affinity for the calcium channel alpha-2-delta subunit |
| 01/20/2009 | CA2477839C Nitrogen containing heterocyclic compounds and medicines containing the same |
| 01/20/2009 | CA2465871C Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1 |
| 01/20/2009 | CA2465738C Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists |
| 01/20/2009 | CA2401048C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 01/20/2009 | CA2366268C Pharmaceutical compositions for cns and other disorders |
| 01/20/2009 | CA2355644C Controlled/modified release oral methylphenidate formulations |
| 01/20/2009 | CA2352762C Oral transmucosal delivery |
| 01/20/2009 | CA2339193C Pharmaceutical compositions comprising ibuprofen and domperidone |
| 01/20/2009 | CA2325633C Steroidal sapogenins and their derivatives for treating alzheimer's disease |
| 01/20/2009 | CA2304770C A use of steroidal saponins for the prophylaxis or treatment of dementia, and novel steroidal saponin compounds |
| 01/20/2009 | CA2289880C A therapeutic agent for intractable vasculitis |
| 01/20/2009 | CA2279497C The use of levobupivacaine in facial surgery |
| 01/18/2009 | CA2598948A1 Enhanced formulations of lamotrigine |
| 01/15/2009 | WO2009009768A2 METHODS OF INHIBITING THE FORMATION OF AMYLOID-β DIFFUSABLE LIGANDS USING A ACYLHYDRAZIDE COMPOUNDS |
| 01/15/2009 | WO2009009633A1 Substituted heterocyclic ethers and their use in cns disorders |
| 01/15/2009 | WO2009009529A1 Treatment of progressive neurodegenerative disease with ibudilast |
| 01/15/2009 | WO2009009457A1 Alzheimer's disease-specific micro-rna microarray and related methods |
| 01/15/2009 | WO2009009411A1 Substituted heterocyclic ethers and their use in cns disorders |
| 01/15/2009 | WO2009009278A1 Substituted fluoroethyl ureas as alpha 2 adrenergic agents |
| 01/15/2009 | WO2009008991A2 Dna-pkcs modulates energy regulation and brain function |
| 01/15/2009 | WO2009008980A2 Tetrahydropyranochromene gamma secretase inhibitors |
| 01/15/2009 | WO2009008928A2 Methods for treating nervous system injury and disease |
| 01/15/2009 | WO2009008891A1 Methods of enhancing cognitive function using non-peptidic compounds |
| 01/15/2009 | WO2009008890A1 METHODS OF MODIFYING AMYLOID β OLIGOMERS USING NON-PEPTIDIC COMPOUNDS |
| 01/15/2009 | WO2009008725A2 Molecules for targeting compounds to various selected organs, tissues or tumor cells |
| 01/15/2009 | WO2009008696A1 Pharmaceutical composition comprising the combination of a triazolobenzodiazepine and a selective serotonin reuptake inhibitor |
| 01/15/2009 | WO2009008695A1 Pharmaceutical composition comprising the combination of risperidone (benzisoxazolic agent) and clonazepam (benzodiazepinic agent) and use thereof in psychotic disorders and related pathologies |
| 01/15/2009 | WO2009008694A1 Pharmaceutical composition comprising the combination of an anti-depressive agent and an ansiolytic agent for control and treatment of depressive disorders |
| 01/15/2009 | WO2009008552A1 8-aryl-4-alkylpyrrolo[2,3,4-de]quinolin-5(4h)-one and 8-aryl-4-alkyl-4,5-dihydropyrrolo[2,3,4-de]quinolin-5-ol derivatives |
| 01/15/2009 | WO2009008529A1 Antibody binding specifically to tdp-43 aggregate |
| 01/15/2009 | WO2009008303A1 Process for production of optically active mirtazapine |
| 01/15/2009 | WO2009008019A1 Stable salts of s-adenosylmethionine and process for the preparation thereof |
| 01/15/2009 | WO2009007697A1 New pharmaceutical formulation comprising cannabidiol and tetrahydrocannabidivarin |
| 01/15/2009 | WO2009007696A1 Amino acid derivatives |
| 01/15/2009 | WO2009007457A2 Compounds and methods for modulating rho gtpases |
| 01/15/2009 | WO2009007348A2 Use of antagonists of g protein coupled receptors (gpcrs) for treating diseases caused by agonistic autoantibodies activated gpcrs |
| 01/15/2009 | WO2009007110A2 Combination of benzyl-4,5-dihydro-1h-imidazole derivative and an opiod recptor ligand |
| 01/15/2009 | WO2009006787A1 Composition comprising rotigotine, its use and transdermal patch comprising the composition |
| 01/15/2009 | WO2008144473A3 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/15/2009 | WO2008142140A3 Novel 2,3-diamino-quinazolinone derivatives and their medical use |